• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Coinbase scraps plans for crypto lending program

September 20, 2021 by David Barret Leave a Comment

September 20, 2021

(Reuters) – Coinbase Global Inc has scrapped its plan to launch an interest-yielding USD Coin (USDC) lending program, the cryptocurrency exchange said in a blog post.

The move comes days after U.S. regulators said it would sue Coinbase if it went ahead with its program allowing users to earn interest by lending digital assets.

“As we continue our work to seek regulatory clarity for the crypto industry as a whole, we’ve made the difficult decision not to launch the USDC APY program,” Coinbase’s blog post said. (https://bit.ly/3tVaUuw)

USDC is a stablecoin that is pegged to the U.S. dollar and can be redeemed for $1 on a one-to-one basis.

The crypto exchange also said it has discontinued the waitlist for its USDC APY (annual percentage yield) program, a high-yield alternative to traditional savings accounts that would have paid lenders of USDC to Coinbase a 4% APY.

Coinbase, which said it has seen a rise in crypto interest account in recent times, had been planning to offer a principal guarantee to lenders of USDC in their Coinbase account.

It added that a 4% APY on USDC would provide a customer eight times the national average on high-yield savings accounts, based on a Bankrate.com survey of U.S. savings accounts in June 2021.

(Reporting by Sohini Podder in Bengaluru; Editing by Shailesh Kuber)

Source Link Coinbase scraps plans for crypto lending program

David Barret
David Barret

Related posts:

  1. Guinean political prisoners freed, regional bloc to discuss coup
  2. Pakistan suggests inviting Taliban-run Afghanistan to regional forum
  3. Soccer-Premier clubs could face sanctions if they play South American players
  4. Tigray forces killed 120 civilians in village in Amhara – Ethiopia officials

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Extremely Rare Belalanda Chameleon Found Living 5 Kilometers Outside Its Very Small Range
  • Frogs Are So Vulnerable, How Did They Survive When T. Rex Didn’t?
  • Florida Man Gets Too Close To Bison In Yellowstone, Promptly Finds Out Why This Is A Bad Idea
  • Is A Bone A Worthy Weapon When Fighting The Rancor? What About A T. Rex?
  • Musical Cyborgs: Scientists Influence Cicadas’ Buzz So They Perform Pachelbel’s Canon In D
  • World’s 25 Most Endangered Primates Revealed – And Humans Are To Blame
  • Watch As Stadium-Sized Asteroid, Largest Of 5, Flies By Earth
  • Deleting “Mitch” Protein From Cells Could Make Humans “Immune” To Obesity
  • Antarctic Glacier Has Been Spotted Committing “Ice Piracy” On Its Neighbor
  • Bat Virus Evolution Suggests COVID-19 Virus Emerged Naturally, Spreading To Humans Through Wildlife Trade
  • Heart Attack Vs Cardiac Arrest: What’s The Difference?
  • Musk Outlines The Questionable Reason He Wants To Get To Mars So Badly, NASA Astronaut Responds
  • In 1972 The Soviets Launched A Spacecraft Bound For Venus. In The Next Few Days, It Will Return To Earth
  • Sounds From Inside A Star Reveal Unexpected Properties Of An Aging Orange Dwarf
  • Hear An Elephant Reunion Spark Sounds Even Keepers Had Not Heard Before
  • Why Do Elevators Have Mirrors Inside Them?
  • Cuttlefish Communicate With Arm Waving And Can Sense The Ripples With Their Bodies
  • First Ever Fatal Bear Attack In Florida Leads To The Deaths Of 3 Black Bears
  • Pathogenic Fungal Spores Found Surviving Miles Above Our Heads In Earth’s Stratosphere
  • “Alchemy” In Action As CERN Detects Lead Atoms Turning Into Gold
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version